Management of Refractory Orofacial Dyskinesia Caused by Anti-N-methyl-d-aspartate Receptor Encephalitis Using Botulinum Toxin

Management of Refractory Orofacial Dyskinesia Caused by Anti-N-methyl-d-aspartate Receptor Encephalitis Using Botulinum Toxin

The use of botulinum neurotoxin serotype A (BoNT-A) injections for the treatment of orofacial dyskinesia secondary to anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is rarely reported. Here, we report a case of an urgent, successful management of severe orofacial dyskinesia in an 8-year-old...

Full description

Bibliographic Details
Main Authors: Feixia Zheng, Xiuyun Ye, Xulai Shi, Neha Devi Poonit, Zhongdong Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-02-01
Series:Frontiers in Neurology
Subjects:
anti-N-methyl-d-aspartate receptor encephalitis
dyskinesia
botulinum toxin
stereotypic movement disorder
vecuronium
rituximab
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2018.00081/full

Internet

http://journal.frontiersin.org/article/10.3389/fneur.2018.00081/full

Similar Items